# OnCo record swog-9916 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/swog-9916/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "swog-9916", "NCT00004001" ;
  schema:name "SWOG 9916"@en ;
  schema:alternateName "SWOG 9916"@en, "S9916"@en, "INT-0161"@en ;
  schema:description "The second trial published the same day as TAX 327, showing the same thing by a different route: docetaxel beats mitoxantrone, though the partner drug it used has since been dropped for its side effects."@en ;
  schema:url <https://onco.cc/trials/swog-9916/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00004001>, <https://doi.org/10.1056/NEJMoa041318> ;
  onco:status "positive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/docetaxel/>, <https://onco.cc/drugs/estramustine/>, <https://onco.cc/drugs/mitoxantrone/>, <https://onco.cc/drugs/prednisone/> ;
  onco:companies <https://onco.cc/companies/swog/> ;
  onco:terms <https://onco.cc/terms/castration-resistance/>, <https://onco.cc/terms/psa50/> ;
  onco:trials <https://onco.cc/trials/tax-327/> .